SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/5F013C5432F5163ECA65DD58B8F1E3CC7ED985F020C894C8C6147B8C42CC6F418E4790367F1A33A0AD9E403DA1F9D527>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/5F013C5432F5163ECA65DD58B8F1E3CC7ED985F020C894C8C6147B8C42CC6F418E4790367F1A33A0AD9E403DA1F9D527
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/5F013C5432F5163ECA65DD58B8F1E3CC7ED985F020C894C8C6147B8C42CC6F418E4790367F1A33A0AD9E403DA1F9D527
http://www.w3.org/2000/01/rdf-schema#comment
"Diminished RXRbeta expression might be related to prostate cancer progression. Because responsiveness to retinoic acid treatments depends on expression of different receptors it is important to study their expression before therapy."
xsd:string
http://purl.uniprot.org/uniprot/#_3AC55835952D47080FA245186EC99C42EA82A239D58E0209789A46BB827FB138EA8C6638F9BBF4ED67B256AB54D7F327
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/5F013C5432F5163ECA65DD58B8F1E3CC7ED985F020C894C8C6147B8C42CC6F418E4790367F1A33A0AD9E403DA1F9D527
http://purl.uniprot.org/uniprot/P28702
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5F013C5432F5163ECA65DD58B8F1E3CC7ED985F020C894C8C6147B8C42CC6F418E4790367F1A33A0AD9E403DA1F9D527
http://purl.uniprot.org/uniprot/#_P28702-mappedCitation-12514092
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/5F013C5432F5163ECA65DD58B8F1E3CC7ED985F020C894C8C6147B8C42CC6F418E4790367F1A33A0AD9E403DA1F9D527